# Finrenone Session Progress — 2026-04-10

## Completed

1. **v16 propagation to 17 sibling apps** (commit `81b4d4b`)
   - CumulativeEngine, ProvenanceChainEngine, QAEngine, CrossValidationEngine + CSS
   - 120 changes, 18 files, all validated (18/18 Edge smoke test, 8/8 benchmark concordance)
   - Backups at `*.pre_v16.bak.html`

2. **26 new living MA apps generated** (commit `590fcb5`)
   - All 26 APPS entries in `generate_living_ma_v13.py` successfully generated
   - Output dirs: `C:\Projects\*_LivingMeta\`
   - All generated from v16 template — already have all engines
   - Topics: PFA_AF, WATCHMAN_AMULET, TRICUSPID_TEER, INCLISIRAN, TIRZEPATIDE_CV,
     SEMAGLUTIDE_HFPEF, LEADLESS_PACING, CSP, CORONARY_IVL, OMECAMTIV, CTFFR,
     VERICIGUAT, SOTAGLIFLOZIN, TDXd_BREAST, OSIMERTINIB_NSCLC, ANTI_AMYLOID_AD,
     RESMETIROM_MASH, SEMAGLUTIDE_CKD, TICAGRELOR_MONO, SOTATERCEPT_PAH,
     ICOSAPENT_ETHYL, K_BINDERS, EMPA_MI, DCB_PAD, ORFORGLIPRON, OBESITY_NMA

3. **Dose-response activated** for 2 apps:
   - TIRZEPATIDE_CV: SURMOUNT-1 data (5/10/15mg, weight change wk 72)
   - OBESITY_NMA: Cross-drug landscape (tirzepatide 5/10/15mg + semaglutide 2.4mg + orforglipron 36mg)

4. **39 repos pushed to GitHub** — all Pages enabled
   - 26 committed + pushed with regenerated v16 apps
   - 2 new repos created (DCB_PAD, Orforglipron)
   - 37/37 GitHub Pages confirmed enabled

5. **Testing against published MAs** — in progress

## Remaining

- [ ] Update INDEX.md with all new projects
- [ ] Update E156 workbook entries
- [ ] Write E156 micro-papers for key topics
